Patient Stories
We would rather show you fewer stories, verified, than a wall of generic testimonials. This page will grow as our own patients consent to share their experience.
In the news: international CAR-T outcomes reported independently
In September 2026, Asia Times reported on a 25-year-old lymphoma patient from New Zealand who, after unsuccessful treatment at home and a US$600,000 quote from a Melbourne hospital, was treated with CAR-T therapy in Shanghai and reached complete remission — at under half the Melbourne quote. The same report also noted an important caution: an early remission is not proof a given hospital or country offers better cancer care generally, since patients able to travel for treatment are a selected group, and the article specifically called for better post-treatment follow-up infrastructure between countries. We include this example because it is independently reported and representative of the broader trend, not because this patient was a CellBridge China client.
We did not treat or coordinate this patient's case. It is cited here as public-interest reporting on the broader trend of international CAR-T treatment in China.
[Placeholder — your verified patient stories go here]
Before publishing any patient story on this page:
- Obtain explicit, written, informed consent for publication, specifying exactly what will be shared (name, photo, diagnosis, outcome) and for how long.
- Make clear that outcomes vary and that one patient's result does not predict another's.
- Avoid implying a guarantee of remission, cure or any specific result.
- Consider anonymizing details (first name only, approximate age, country) if the patient prefers privacy while still wanting to help others.
Your first consented patient story will appear here.